Prodimol Biotecnologia

Prodimol Biotecnologia is a Brazilian biotechnology company specializing in the development, manufacture, and distribution of diagnostic products and molecular biology reagents. Founded in 2003 as a spin-off from Biobrás, the company established itself as a leading player in the Brazilian diagnostics market, providing rapid tests for infectious diseases, oncology, and women's health. In 2008, Prodimol was acquired by Inverness Medical Innovations (now part of Abbott) to serve as a strategic base for its operations in South America. The company's portfolio includes a wide range of clinical diagnostic kits, culture media, and laboratory instruments suitable for both professional and point-of-care settings.